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Abstract

Approximately 1 in 3 American adults has prediabetes, a condition characterized by blood glucose levels that are
above normal, not in the type 2 diabetes ranges, and that increases the risk of developing type 2 diabetes. Evidencebased treatments can be used to prevent or delay type 2 diabetes in adults with prediabetes. The American Medical
Association (AMA) has collaborated with health care organizations across the country to build sustainable diabetes
prevention strategies. In 2017, the AMA formed the Diabetes Prevention Best Practices Workgroup (DPBP) with
representatives from 6 health care organizations actively implementing diabetes prevention. Each organization had
a unique strategy, but all included the National Diabetes Prevention Program lifestyle change program as a core
evidence-based intervention. DPBP established the goal of disseminating best practices to guide other health care
organizations in implementing diabetes prevention and identifying and managing patients with prediabetes.
Workgroup members recognized similarities in some of their basic steps and considerations and synthesized their
practices to develop best practice recommendations for 3 strategy maturity phases. Recommendations for each
maturity phase are classified into 6 categories: (1) organizational support; (2) workforce and funding; (3) promotion
and dissemination; (4) clinical integration and support; (5) evaluation and outcomes; (6) and program. As the
burden of chronic disease grows, prevention must be prioritized and integrated into health care. These maturity
phases and best practice recommendations can be used by any health care organization committed to diabetes
prevention. Further research is suggested to assess the impact and adoption of diabetes prevention best practices.
Keywords: prediabetes, diabetes prevention best practices, National Diabetes Prevention Program, lifestyle
change program, American Medical Association
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Introduction

D

iabetes mellitus is one of the nation’s most prevalent
chronic diseases, currently affecting more than 34 million
Americans1 and leading to increasing economic and social
burdens. At the same time, approximately 1 in 3 American
adults has prediabetes,1 a condition that is characterized by
blood glucose levels that are above normal but not high enough
to be diagnosed as type 2 diabetes. Individuals with prediabetes are at increased risk of progression to type 2 diabetes, yet
more than 84% are unaware that they have this condition.1
Type 2 diabetes can potentially be prevented or delayed in
adults with prediabetes through evidence-based treatments.
The landmark US Diabetes Prevention Program (DPP) study
demonstrated that intensive lifestyle intervention was effective at reducing the incidence of type 2 diabetes. At approximately 3 years follow-up, the incidence of diabetes was
58% lower among those who received intensive lifestyle intervention compared to those who received placebo treatment.2 Since this study, lifestyle interventions for the
prevention of type 2 diabetes have been successfully translated and delivered in a variety of settings and modalities.3–8
Based on evidence from the DPP study and subsequent
translational studies, Congress authorized the Centers for
Disease Control and Prevention (CDC) to establish the
National Diabetes Prevention Program (National DPP) lifestyle
change program in 2010 to address the rising incidence of type
2 diabetes.9 The program is a structured and group-based intensive behavioral change program designed to help adults
with overweight or obesity who are at risk for type 2 diabetes to prevent or delay its onset. During the first 4 years
(February 2012 through January 2016) of program implementation, 14,747 adults were enrolled and attended a
median of 14 sessions over an average of 172 days.10 As of
April 2019, more than 324,000 individuals have participated in
the National DPP lifestyle change program offered by more
than 3000 partner organizations.11 Currently, there are more
than 1800 in-person, online, and/or distance learning lifestyle change programs offered by health care organizations,
community-based organizations, and digital health providers
registered with the National Diabetes Recognition Program.12
American Medical Association Diabetes
Prevention Workgroup

The American Medical Association (AMA) established
the prevention of type 2 diabetes as a long-term strategic
goal in 2012 and has collaborated with health care organizations across the country to build sustainable diabetes
prevention strategies. In 2017, the AMA formed the Diabetes Prevention Best Practices Workgroup (DPBP) with
representatives from 6 health care organizations actively
implementing diabetes prevention: Henry Ford Health System; Intermountain Healthcare; Loma Linda University
Health; University of South Carolina School of MedicineColumbia Campus; Trinity Health; and University of California, Los Angeles, (UCLA) Health.* DPBP established
the goal of disseminating best practices to guide other health
care organizations in implementing diabetes prevention
strategies that identify and manage patients with prediabetes. Each organization had a unique strategy, but all included the National DPP lifestyle change program as a core
evidence-based intervention. Organizations delivering the
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National DPP lifestyle change program must meet national
standards to ensure fidelity and quality, including the use of
certified coaches and curriculum and close tracking of participant physical activity minutes and weight. Recognition as a
DPP lifestyle change program by the CDC requires achievement of specific performance metrics. At the time of manuscript submission, these metrics included an average weight
loss of 5% and minimum engagement standards among participants. The DPBP organizations are all fully recognized by
the CDC, indicating that these standards and performance
metrics are being successfully met and sustained over time.
Although there were varying models of implementation at
each organization, it became clear that some basic steps and
considerations were common among these diverse systems.
With this awareness, the DPBP synthesized the best practice
implementation recommendations that will be presented in
the following sections for other health care organizations.
This process spanned 2 years and included in-person
meetings, conference calls, and semi-structured interviews
with teams from each DPBP member organization. These
teams consisted of individuals with varied professional
qualifications, including endocrinology, primary care medicine, sports medicine, physical therapy, nutrition, osteopathic
medicine, cardiovascular health, medical administration, research, community health, and nursing. Common activities
conducted at DPBP institutions formed the foundation for the
recommendations. The diverse geographic locations and patient populations served by DPBP members and their multidisciplinary professional backgrounds support the broad
applicability of the recommendations. Each DPBP member
collected metrics specific to her/his organization’s diabetes
prevention strategy and maturity phase.
Implementation Maturity Phases

Implementing diabetes prevention at a system level usually involves several stages over time. DPBP grouped
implementation-structured activities into 3 strategy maturity
phases: (1) Getting Started, (2) Planning for Growth, and (3)
Advancing Innovation (Tables 1–3). Although the three
phases interconnect, each has distinct and specific characteristics that can propel the organization into the next phase,
and activities may repeat themselves in each phase.
The Getting Started phase (Table 1) is the start-up period
during which an organization obtains organizational support
and commits to establishing a diabetes prevention strategy
that offers treatment options for prediabetes, such as a CDCrecognized lifestyle change program, secures the necessary
workforce and funding, and establishes a National DPP lifestyle change program offering. Planning for Growth (Table 2)
is the subsequent phase during which an organization advances the strategy by increasing overall awareness, building
infrastructure, expanding clinical engagement, offering the
National DPP lifestyle change program to additional sites, or
further developing the program curricula and coaches to expand program reach and enrollment. The Advancing Innovation phase (Table 3) occurs when diabetes prevention
becomes part of routine clinical operations for an organization and the focus is on population management and sustainability. At this point, strategy milestones and processes
can be broadly shared and insights from implementation can
be applied to other quality improvement initiatives.

DIABETES PREVENTION IMPLEMENTATION: BEST PRACTICES
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Table 1. Best Practice Recommendations for Getting Started Maturity Phase
Key focus areas are to obtain organizational support, secure workforce and funding resources, and begin offering a National
Diabetes Prevention Program (National DPP) lifestyle change program.
Organizational Support
 Align diabetes prevention strategy (strategy) goals and expected outcomes with the organization’s strategic plan and
mission.
 Use available data, such as Community Health Needs Assessment results and community and patient diabetes data, to
illustrate the return on investment and anticipated improvement in health outcomes from the strategy.
 Form an interdisciplinary leadership/advisory group to guide strategy and increase visibility.
Workforce and Funding
 Develop a budget and estimate the short-term and long-term costs of the strategy; conduct networking to secure the
necessary resources.
 Identify the available workforce and build an interdisciplinary project team to execute strategy activities.
 Identify existing short-term and long-term funding sources, such as community benefit dollars, grants, and insurer
benefits.
Promotion and Dissemination
 Develop a communications and outreach plan along with key messages about strategy for the entire organization and
community.
 Share success stories and outcomes from strategy implementation early, often, and in many venues.
 Use available existing materials and educational resources, such as posters, flyers, and handouts.
Clinical Integration and Support
 Identify and recruit clinical champions, including providers and other care team members.
 Adapt processes to increase prediabetes identification and management, and facilitate referrals to a National DPP
lifestyle change program.
 Determine the process to integrate clinical decision-support tools and other health information technology, and begin to
engage key stakeholders.
Evaluation and Outcomes
 Define the goals of the strategy and the criteria for success.
 Develop quantitative and qualitative assessments of strategy progress that include informal feedback from key
stakeholders, such as patients, physicians, and lifestyle change program coaches.
 Determine the metrics to assess the current state of identification and management of patients with prediabetes, and use
the results to guide activities.
Program (National DPP Lifestyle Change Program)
 Obtain guidance and technical assistance as needed for adhering to the CDC standards and achieving recognition;
establish processes for collecting and submitting required CDC reporting metrics.
 Monitor lifestyle change program outcomes and identify areas of success and areas for improvement.
 Incorporate structured onboarding and skills development for coordinators and coaches.
 Develop quality assurance methods, such as structured performance feedback for coaches, for delivery of a lifestyle
change program.
Reproduced with permission from the American Medical Association. This Table may be photocopied noncommercially by physicians,
educators, and other health care professionals to use for educational purposes. Please address all other permissions to the AMA. Notwithstanding
publication in Population Health Management, AMA retains all of its copyright and other intellectual property rights in the foregoing.
ª 2020 American Medical Association. All rights reserved.
AMA, American Medical Association; CDC, Centers for Disease Control and Prevention; DPP, Diabetes Prevention Program.

As an organization completes each maturity phase, the
reach and population effects of a strategy likely will increase; however, benefits of a strategy are seen in all phases
as patients with prediabetes receive an evidence-based
intervention. Although the maturity phases are sequential,
the timing for each phase is variable. Organizations may opt
to remain in one phase longer, or some organizations may
require less time than others to execute a phase, depending
on prior experience with diabetes prevention. For example,
an organization that has an established CDC-recognized
National DPP lifestyle change program may progress
through Getting Started within a few weeks, whereas an
organization that is starting a new program may need
months to progress in this phase.
DPBP outlined best practice implementation recommendations for each maturity phase, which are presented in
Tables 1–3. The recommendations are classified into 6
overarching categories:

Organizational support recommendations encompass implementation activities that assist with obtaining leadership
buy-in, demonstrating alignment with organizational mission, and sharing the expected or actual impact and return on
investment from implementing diabetes prevention.
Workforce and funding recommendations focus on securing
and maintaining the resources and team members needed to
execute and sustain a diabetes prevention strategy. Interdisciplinary teams are essential and include ambulatory clinical
care team members, data analysts, researchers, clinical operations personnel, health coaches, and diabetes educators as potential core team members.
Promotion and dissemination recommendations concentrate
on raising awareness of a strategy, sharing success stories,
and publicizing and/or publishing results within and outside
an organization.
Evaluation and outcomes recommendations center on measuring the impact and progress of the strategy and supporting
the collection of quantitative and qualitative metrics and data.
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Table 2. Best Practice Recommendations for Planning for Growth Maturity Phase
Key focus areas are to increase and systemize clinical engagement, increase overall awareness of strategy, and expand
program and prediabetes management.
Organizational Support
 Continue to cultivate leadership support for the diabetes prevention strategy (strategy) through regular updates and
results.
 Query stakeholders to determine ways to increase support for the strategy, and adjust activities based on feedback.
 Pilot a quality improvement initiative or incentive for diabetes prevention.
Workforce and Funding
 Identify additional business units and departments to engage in the strategy, such as clinical operations.
 Estimate resources needed to increase reach and spread of the strategy; develop a cost-effective, feasible plan for
expansion.
 Secure ongoing funding of the strategy, such as community health and benefits budgets.
Promotion and Dissemination
 Use marketing and communications to increase overall awareness of the strategy both inside and outside the
organization.
 Create or identify forums to share strategy benefits and outcomes.
 Highlight aggregate outcomes from program participation, such as reduction in weight and increase in physical activity.
Clinical Integration and Support
 Leverage existing champions and recruit additional champions to expand awareness and clinical engagement in the
strategy.
 Provide education to all clinical care teams on the identification and management of patients with prediabetes; consider
offering training on shared decision-making and counseling techniques.
 Integrate and optimize clinical decision-support tools and health information tools for prediabetes, such as referral
platforms.
 Improve and standardize referral and bidirectional feedback processes between clinical care teams and lifestyle change
program providers.
Evaluation and Outcomes
 Begin to collect and monitor clinical metrics, such as the number of patients with prediabetes who receive a referral to a
National Diabetes Prevention Program (National DPP) lifestyle change program.
 Expand the initial qualitative and quantitative evaluation methods.
 Continue to monitor the progress and impact of the strategy.
Program (National DPP Lifestyle Change Program)
 Automate processes for collecting and submitting required metrics for program recognition; continue to regularly
monitor the delivery quality and metrics of the lifestyle change program.
 Establish an ongoing coach, staff a professional development program, and offer additional skills training, such as
motivational interviewing.
 Select and certify coaches to become master trainers for the lifestyle change program.
 Consider expanding program offerings, such as group physical activity opportunities, based on participant requests and
needs.
Reproduced with permission from the American Medical Association. This Table may be photocopied noncommercially by physicians,
educators, and other health care professionals to use for educational purposes. Please address all other permissions to the AMA.
Notwithstanding publication in Population Health Management, AMA retains all of its copyright and other intellectual property rights in the
foregoing.
ª 2020 American Medical Association. All rights reserved.
AMA, American Medical Association; DPP, Diabetes Prevention Program.

Clinical integration and support recommendations outline
activities to increase engagement from clinical care teams
and improve the identification, referral numbers, and management of patients with prediabetes.
Program recommendations support the activities associated
with the launch and expansion of a high-quality National DPP
lifestyle change program offering or collaboration with an external community-based National DPP lifestyle change program.

When planning or executing within these 6 overarching
categories, certain foundational structural processes and
principles apply throughout all implementation phases and
activities. DPBP noted that although variability among
health care organizations in patient demographics exists,
leadership teams must ensure throughout the planning and
implementation process that from historically marginalized/

minoritized communities are receiving the benefits of the
diabetes prevention strategy. It is essential to apply a health
equity lens in the development of all diabetes prevention
activities and processes. The purpose of an equity lens is to
be deliberately inclusive as an organization makes decisions
on process and outcomes. This also ensures that patients
with prediabetes are identified and managed with culturally
competent care throughout all diabetes prevention phases.
Other foundational processes include the optimization of
health information and digital health technology to ensure that
the diabetes prevention strategy is linked to the continuum of
care for each patient. To successfully integrate clinical decision
support tools and other health information technology, the
identification of key stakeholders within the organization needs
to be applied consistently throughout the maturity phases.

DIABETES PREVENTION IMPLEMENTATION: BEST PRACTICES
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Table 3. Best Practice Recommendations for Advancing Innovation Maturity Phase
Key focus areas are to share achievements and ensure the sustainability of strategy and improvements.
Organizational Support
 Ensure continued visibility and provide regular updates on the diabetes prevention strategy (strategy) to the
organization’s leadership.
 Adopt system-wide goals or incentives for diabetes prevention that align vertically and laterally (eg, leadership goals
align with clinical care team goals).
Workforce and Funding
 Use an established advisory group, champions, and project team for other prevention initiatives.
 Monitor operational costs and maintain the cost-effectiveness of the strategy.
 Secure additional funding sources for the strategy, such as reimbursement for the National Diabetes Prevention
Program (National DPP) lifestyle change program through insurance coverage or employer benefits.
Promotion and Dissemination
 Continue to highlight success stories that demonstrate the benefit of the strategy to the organization and the larger
community.
 Externally publish and present learnings and results of the strategy.
 Advocate for diabetes prevention locally and nationally through such activities as writing commentaries, white papers,
or legislative briefings or responding to open comments for programs and policies.
Clinical Integration and Support
 Provide regular reporting to care teams on metrics related to prediabetes identification and management; address any
negative trends, such as decreased program referral rates.
 Use the entire care team to identify and manage patients with prediabetes.
 Offer multiple evidence-based treatment options for patients with prediabetes.
Evaluation and Outcomes
 Track population-level outcomes and additional health outcomes, such as reductions in blood glucose levels or the
incidence of diabetes.
 Revise existing metrics and evaluation methods as needed.
 Solicit ongoing feedback on the strategy from all stakeholders.
 Consider data exchange with external sources, such as health plans and state health departments, to improve local and
national efforts related to diabetes prevention.
Program (National DPP Lifestyle Change Program)
 Create a multidirectional communication flow and enable care coordination between the lifestyle change program,
clinical care teams, patients, and other service organizations to address participant needs.
 Continue to monitor the quality and process the efficiency of the lifestyle change program.
 Offer advanced skills training or cross-train coaches to deliver other programs.
 Monitor and address coordinator and coach attrition.
Reproduced with permission from the American Medical Association. This Table may be photocopied noncommercially by physicians,
educators, and other health care professionals to use for educational purposes. Please address all other permissions to the AMA.
Notwithstanding publication in Population Health Management, AMA retains all of its copyright and other intellectual property rights in the
foregoing.
ª 2020 American Medical Association. All rights reserved.
AMA, American Medical Association; DPP, Diabetes Prevention Program.

Implementation Road Map: Demonstrating
Best Practice

The best practice implementation recommendations developed by DPBP can be used by health care organizations
as a road map in each maturity phase.
Getting started phase

During the Getting Started phase, obtaining organizational support and establishing the necessary resources for
workforce and funding are often the initial requisite steps,
and assessing existing resources can be helpful. For example, the Henry Ford Health System team identified an established group of faith-based nurses to deliver the National
DPP lifestyle change program. The nurses were already
embedded in the community and training them as lifestyle
coaches allowed the team to begin offering the program in
many locations. Loma Linda University Health team
members included faculty and students from the university’s

School of Public Health as well as fitness center staff who
delivered the program, and clinical care case managers who
recruited eligible patients.
To help gain initial buy-in across the organization, existing data such as local diabetes prevalence rates can be
highlighted. Trinity Health used results from its Community
Health Needs Assessment to incorporate funding for National DPP lifestyle change program offerings into its
community health and benefits budget.
Stakeholder engagement is critical because diverse
groups (in and out of the organization) can synergistically
help make the case for implementing and sustaining diabetes prevention services. In the case of UCLA Health,
the diabetes prevention team was able to form a partnership with departments that are not traditionally linked to
clinical care or clinical operations, such as campus recreation services, occupational health, and human resources. This team diversity helped achieve broad
organizational support.

6
Planning for growth phase

In the Planning for Growth phase, clinical engagement
and endorsement, integration of digital health tools, and
dissemination of strategy processes and metrics can drive
expansion. Engaging clinical champions and educating care
teams can raise overall awareness of a diabetes prevention
strategy. Thus, partnership with clinical champions increases needed buy-in from frontline clinical providers who
may help identify, refer, and encourage patients to participate in the National DPP lifestyle change program offering.
Training members of care teams on specific counseling or
communication techniques to address prediabetes with patients also can improve the overall identification and management of prediabetes. At UCLA Health, pharmacists
engaged in a shared decision-making process with identified
patients on their prediabetes treatment options; patients who
participated in this process had an increased uptake of the
National DPP lifestyle change program and/or metformin.13
Incorporating digital health tools to support systematic
identification and management of prediabetes, including
referrals to programs, also can drive further clinical engagement. For example, Loma Linda University Health experienced an uptrend in referrals to the National DPP lifestyle
change program when an electronic referral order was made
available and providers were educated on the National DPP
lifestyle change program as a resource for their patients. The
Henry Ford Health System also recognized the potential role
technology could play in advancing its strategy and implemented a diabetes prevention module within its electronic
health record that included best practice alerts, an electronic
referral to its National DPP lifestyle change program, and a
prediabetes registry. Processes for National DPP lifestyle
change program referrals and bidirectional feedback between
program providers and care teams were refined and standardized to maximize efficiency and utility. Collectively,
these changes led to a significant increase in the number of
clinical referrals and improved patient outcomes.
Another strategy emphasized by DPBP is to increase support from key system stakeholders for diabetes prevention by
consistently sharing data and metrics regarding program processes and outcomes. For example, University of South Carolina Family Medicine implemented a quality improvement
project with its residents that focused on ensuring all patients
eligible for abnormal glucose screening were receiving the
necessary laboratory testing and that those with prediabetes
were formally diagnosed and counseled on treatment options.
The team recognized that emphasizing identification along
with program referral was necessary to the success of its
strategy and used data to help drive improvement in prediabetes identification and management.
The Planning for Growth phase also presents new opportunities, such as additional skills training for lifestyle
coaches, to build capacity and longevity of a National DPP
lifestyle change program offering. Trinity Health has trained
its lifestyle coaches in motivational interviewing to improve
participant engagement and retention, whereas UCLA
Health and the Henry Ford Health System have internal
master trainers to train new coaches in their organizations.
Programs also may augment and enhance their offerings
to meet participant needs. For example, Loma Linda University Health provided participants with free memberships
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to its fitness center, and lifestyle coaches led group physical
activity for participants interested in exercising together
after regularly scheduled program sessions.
Advancing innovation phase

In the Advancing Innovation phase, strategy sustainability
is a key focus. By this phase, diabetes prevention should be
part of routine clinical processes of care, and organizations
should be offering a variety of treatment options for prediabetes. For example, Intermountain Healthcare developed a
care process model for its entire system that includes the
National DPP lifestyle change program, an introductory
prediabetes educational session, medical nutrition therapy,
and pharmacotherapy as options in managing patients with
prediabetes.
The Advancing Innovation phase is also an appropriate
time for health care organizations to use promotion and
dissemination to broadly share strategy achievements.
Complex mixed method evaluation and outcomes tracking
can help organizations demonstrate long-term sustainability
of a strategy. Intermountain Healthcare developed a method
to track the conversion rates of patients with prediabetes to
type 2 diabetes to demonstrate the lasting benefit of this
work. This sophisticated evaluation builds in opportunities
to test and adapt the strategy activities to meet the changing
health care landscape.
Many DPBP members have presented or published details
of their diabetes prevention strategies at national conferences and in peer-reviewed journals,13–22 whereas others
have disseminated their results in less formal ways. These
range from ongoing presentations at internal medical group
summits, to huddle discussions, to participation in prevention workgroups such as the DPBP.
Conclusion

As the burden of chronic disease in the United States and
worldwide grows, prevention must be prioritized and integrated into health care. The recent public health emergency
(PHE) and COVID-19 pandemic have demonstrated the
need to prioritize prevention of chronic disease, health equity, and investing in new models of delivery. During the
PHE, DPBP members continued to support and engage in
diabetes prevention activities, pivoting to offer the National
DPP lifestyle change program using virtual platforms to
maintain offerings and observed continued clinical and
participant engagement. Previous and future publications
from DPBP organizations may offer more details about each
strategy and results.
More work is needed to explore innovation and advance
equity within diabetes prevention. The maturity phases and
best practice implementation recommendations outlined
herein can be used by any health care organization committed to diabetes prevention to launch and sustain an effective strategy and improve the health of patients and
communities. Further research is suggested to assess the
impact and adoption of diabetes prevention best practices.
*Diabetes Prevention Best Practices Workgroup Members and Health Care Organizations Represented
Gina C. Aquino, MSN, RN, CHSP, RN, Henry Ford
Health System; Ameldia R. Brown, M.Div., BSN, RN,
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Henry Ford Health System; Christopher O’Connell, DO,
CPE, Henry Ford Health System; Elizabeth Joy, MD, MPH,
Intermountain Healthcare; Kimberly D. Brunisholz PhD,
MST, Intermountain Healthcare; Tannaz Moin, MD, MBA,
MSHS, University of California, Los Angeles, Health; O.
Kenrik Duru, MD, MSHS, University of California, Los
Angeles, Health; Holly Craig-Buckholtz, MBA, BSN, RN,
Loma Linda University Health; Brenda Rea MD, DrPH, PT,
RD, Loma Linda University Health; Patricia W Witherspoon, MD, FAAFP, University of South Carolina; Cindy
Bruett, Trinity Health.
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